Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): A randomised, double-blind, placebo-controlled trial
Document Type
Journal Article
Publication Date
1-21-2012
Journal
The Lancet
Volume
Volume 379, Issue 9812
Inclusive Pages
221-228
Keywords
Anti-HIV Agents--therapeutic use; Breast Feeding; HIV Infections--prevention & control; HIV-1; Infectious Disease Transmission; Vertical--prevention & control; Nevirapine--administration & dosage; Pregnancy Complications; Infectious--drug therapy
APA Citation
Coovadia, H. M., Brown, E. R., Fowler, M. G., Chipato, T., Moodley, D., Manji, K., Musoke, P., Stranix-Chibanda, L., Chetty, V., Fawzi, W., Nakabiito, C., Msweli, L., Kisenge, R., Guay, L., Mwatha, A., Lynn, D.J., Eshleman, S.H., Richardson, P., George, K., Andrew, P., Mofenson, L.M.l, Zwerski, S., Maldonado, Y. (2012). Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): A randomised, double-blind, placebo-controlled trial. The Lancet, 379(9812), 221-228.
Peer Reviewed
1
Open Access
1
Comments
This is an open access PubMed Central article. Click on link for full-text access.